Magnetic Resonance Angiography (MRA) News and Research

RSS

NIH funds CWRU to investigate new imaging approach for diagnosing peripheral arterial disease

Case Western Reserve University School of Medicine has received a three-year, $1,118,556 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to investigate a new imaging approach for diagnosing peripheral arterial disease, a common and potentially serious circulatory problem. More than 200 million people worldwide suffer from the condition.

18 Sep 2018

New five-minute procedure to scan blood vessels offers hope for claustrophobic patients

Doctors have developed a new five-minute procedure to scan the blood vessels which offers hope for claustrophobic patients unable to tolerate the conventional longer test. The research is presented today at CMR 2018.

6 Feb 2018

Experiments in big animals show efficacy of new non-toxic MRI contrast agent

The top causes of death worldwide, ischemic heart diseases and stroke, together with another major source of illness, that is cancer, require proper imaging of blood vessels.

31 Jul 2017

Non-contrast MRA can be viable diagnostic alternative for patients with chronic kidney disease

Patients with diabetes or renal failure are at high risk for deadly and debilitating vascular diseases, however, the most common imaging tool to evaluate the blood vessels uses a contrast agent that can further damage the kidneys.

30 Sep 2016

CMR could offer complete imaging solution before pulmonary vein isolation

Cardiac magnetic resonance can potentially be used to detect thrombi at the same time as being used for pulmonary venous anatomy mapping, say researchers

4 Jun 2016

Study shows how MRA and CTA are equivalent in delineating anatomy in living renal donors

A new study from UCLA shows how magnetic resonance angiography (MRA) and computed tomography angiography (CTA) are equivalent in delineating anatomy in living renal donors.

30 Apr 2012

Novation, Lantheus Medical to distribute ABLAVAR and DEFINITY diagnostic imaging agents

Lantheus Medical Imaging, a worldwide leader in diagnostic medical imaging, today announced a national contract with Novation for ABLAVAR and DEFINITY Vial For Injectable Suspension, providing increased access to these important diagnostic imaging agents for health care providers served by Novation.

23 Jan 2011

Toshiba announces new Vantage Titan HSR 1.5T MR with high slew rate gradients

Certain MR exams such as advanced cardiac and neuro imaging require a system with enhanced gradients for better image quality and quicker exams. For these applications, Toshiba America Medical Systems, Inc. announces the new Vantage TitanTM HSR 1.5T MR with high slew rate gradients and new user interface, M-Power. Toshiba will showcase the new Vantage Titan HSR (pending 510k clearance) at this year's Radiological Society of North America (RSNA) annual meeting, held in Chicago, Nov. 28 - Dec. 3, 2010 (Booth #3435, South Hall).

2 Dec 2010

Lantheus announces Canadian launch of ABLAVAR injection

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the Canadian launch of ABLAVAR (gadofosveset trisodium injection), a unique, injectable magnetic resonance angiography (MRA) blood pool imaging agent.

15 Oct 2010

Lantheus Medical Imaging supports FDA action to ensure appropriate use of gadolinium-based contrast agents

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, supports the U.S. Food and Drug Administration's (FDA) announcement requiring safety-related label changes for all gadolinium-based contrast agents to highlight the rare and potentially fatal condition known as nephrogenic systemic fibrosis (NSF).

10 Sep 2010

Lantheus Medical Imaging announces the launch of ABLAVAR

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the launch of ABLAVAR™ (gadofosveset trisodium), a unique, injectable MRA imaging agent used to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease (PVD).

20 Jan 2010

Toshiba America Medical Systems installs its 800th Vantage 1.5T MR system

Toshiba America Medical Systems, Inc., an industry leader in magnetic resonance (MR) technology, reached a significant achievement in installing its 800th Vantage 1.5T MR system at Elkview General Hospital in Hobart, Okla. Elkview is using the Vantage system for orthopedic, neuro and abdominal imaging.

25 Aug 2009

Noninvasive screening test may detect narrowing in intracranial stents

Great advances have been made in treating blockages in the arteries of the brain using angioplasty to widen the narrowed artery and a stent to hold the artery open.

15 Feb 2009

Allergic reactions to gadolinium-containing contrast injections - study

Allergic-like reactions to gadolinium-containing contrast injections in adults and pediatric patients (those younger than 19 years of age) are rare, according to a recent study conducted by researchers at the University of Michigan Health Systems in Ann Arbor.

2 Jan 2008

European markets for cardiac catheterisation imaging systems

With a sharp increase in the incidence of cardiovascular disorders and mortalities in Europe, the need for early detection as well as cardiac interventional procedures has created enhanced scope for the uptake of cardiac catheterisation imaging systems.

2 Feb 2006